KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Amortization of Deferred Charges (2018 - 2025)

ClearPoint Neuro's Amortization of Deferred Charges history spans 13 years, with the latest figure at $469000.0 for Q3 2025.

  • For Q3 2025, Amortization of Deferred Charges rose 819.61% year-over-year to $469000.0; the TTM value through Sep 2025 reached $490000.0, up 642.42%, while the annual FY2024 figure was $51000.0, 10.53% down from the prior year.
  • Amortization of Deferred Charges for Q3 2025 was $469000.0 at ClearPoint Neuro, up from $21000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $469000.0 in Q3 2025 and bottomed at -$15000.0 in Q2 2024.
  • The 5-year median for Amortization of Deferred Charges is $15000.0 (2023), against an average of $57529.4.
  • The largest annual shift saw Amortization of Deferred Charges tumbled 207.14% in 2024 before it soared 819.61% in 2025.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $40000.0 in 2021, then tumbled by 65.0% to $14000.0 in 2022, then grew by 7.14% to $15000.0 in 2023, then soared by 240.0% to $51000.0 in 2024, then skyrocketed by 819.61% to $469000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Amortization of Deferred Charges are $469000.0 (Q3 2025), $21000.0 (Q2 2025), and $51000.0 (Q3 2024).